Cargando…
Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis
BACKGROUND & OBJECTIVES: Mycobacterium w (M.w) is a saprophytic cultivable mycobacterium and shares several antigens with M. tuberculosis. It has shown good immunomodulation in leprosy patients. Hence in the present study, the efficacy of M.w immunotherapy, alone or in combination with multi dru...
Autores principales: | Faujdar, Jaya, Gupta, Pushpa, Natrajan, Mohan, Das, Ram, Chauhan, D.S., Katoch, V.M, Gupta, U.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249969/ https://www.ncbi.nlm.nih.gov/pubmed/22199110 http://dx.doi.org/10.4103/0971-5916.90999 |
Ejemplares similares
-
Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung
por: Gupta, Ankan, et al.
Publicado: (2012) -
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial
por: Sharma, Surendra K., et al.
Publicado: (2017) -
T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis()
por: Steigler, Pia, et al.
Publicado: (2022) -
“Mycobacterium indicus pranii” Is a Strain of Mycobacterium intracellulare
por: Alexander, David C., et al.
Publicado: (2015) -
Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine()
por: Gupta, Sunil Kumar, et al.
Publicado: (2022)